CAPTRUST Financial Advisors
NVAX icon

CAPTRUST Financial Advisors’s Novavax NVAX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
+18,675
New +$167K ﹤0.01% 2923
2022
Q3 		– Sell
-6,703
Closed -$345K – 3352
2022
Q2 		$345K Buy
6,703
+3,047
+83% +$158K ﹤0.01% 1343
2022
Q1 		$269K Sell
3,656
-44
-1% -$3.92K ﹤0.01% 1519
2021
Q4 		$529K Buy
3,700
+1,133
+44% +$195K ﹤0.01% 1092
2021
Q3 		$532K Buy
2,567
+1,942
+311% +$428K ﹤0.01% 1001
2021
Q2 		$133K Buy
625
+16
+3% +$2.93K ﹤0.01% 1804
2021
Q1 		$110K Buy
609
+399
+190% +$79.5K ﹤0.01% 1885
2020
Q4 		$23K Buy
210
+27
+15% +$2.87K ﹤0.01% 2183
2020
Q3 		$19K Sell
183
-37
-17% -$4.51K ﹤0.01% 1998
2020
Q2 		$18K Buy
+220
New +$8.41K ﹤0.01% 1981

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

CAPTRUST Financial Advisors's NVAX Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Novavax (NVAX) in Q2 2026: 18,675 shares worth $176K. The stake represents ﹤0.01% of the portfolio and ranks #2923 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in NVAX as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in NVAX in Q2 2020 and has held it in 10 quarters since. The position peaked at $532K in Q3 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • CAPTRUST Financial Advisors held 18,675 shares of Novavax worth $176K as of Q2 2026.
  • Novavax was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Novavax made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2923 holding.
  • CAPTRUST Financial Advisors first reported a position in Novavax in Q2 2020 and has held it in 10 quarters since.
  • CAPTRUST Financial Advisors's Novavax position peaked at $532K in Q3 2021.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.